The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis

Table 2

The associations between nanog overexpression and clinic-pathological features for lung cancer.

Heterogeneity
Clinic-pathological features	No. of studies	No. of patients	Pooled OR (95% CI)	PHet	I^2	P value	Model used
differentiation	4	588	4.17 (2.71-6.43)	0.795	0.0%	≤0.001	Fixed
lymph node metastasis	4	391	1.76 (1.06-2.91)	0.738	0.0%	0.028	Fixed
tumor size	2	276	1.93 (1.17-3.20)	0.462	0.0%	0.010	Fixed
T stage	2	432	0.85 (0.57-1.34)	0.402	0.0%	0.541	Fixed
TNM	4	708	1.22 (0.88-1.68)	0.472	0.0%	0.227	Fixed
gender	7	812	1.19 (0.87-1.62)	0.546	0.0%	0.287	Fixed

Random, random-effects model; fixed, fixed-effects model; OR, odds ratio; CI, confidence interval; NO, number of sample size.